A CASE OF DEVELOPMENT OF CARDIOGENIC SHOCK AFTER INTRA-ARTERIAL INJECTION OF PAPAVERINE DURING MEASURING OF FRACTIONAL FLOW RESERVE IN LEFT ANTERIOR DESCENDING ARTERY
https://doi.org/10.29001/2073-8552-2017-32-4-59-64
Abstract
Myocardial infarction complicated by cardiogenic shock is a rare but severe iatrogenic complication of invasive procedures. Damage of microcirculatory vessels; microcirculatory disorder, oedema of pericapillary tissues; embolization by microcrystals of contrast agent and platelet masses; inflammatory reaction in response to histamine release, dysfunctions of the heart’s autonomic nervous system cause “No-reflow” and “Slow-reflow” phenomena which leads to the development of pathological condition. In this case, a choice of interventions tactics depends on physician and is determined individually in each separate case, nevertheless the need of complete myocardial revascularization seems obvious.
About the Authors
E. N. SemukhinaRussian Federation
Cand. Sci. (Med.), Researcher, Cardiologist
M. V. Semukhin
Russian Federation
Cand. Sci. (Med.), Invasive Cardiologist, Department of X-ray and Surgery Methods of Diagnostics and Treatment No. 1
L. I. Gapon
Russian Federation
Dr. Sci. (Med.), Professor, Honored Scientist of the Russian Federation, Head of Clinical Cardiology Science Department
I. P. Zyryanov
Russian Federation
Cand. Sci. (Med.), Honored Doctor of the Russian Federation, Deputy Director for Scientific and Medical Work, Head of Department of X-ray and Surgery Methods of Diagnostics and Treatment No. 1, Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Sciences; Chief Non-Staff Specialist in Invasive Cardiology in the Ural Federal District
References
1. Erne P., Schoenenberger A.W., Burckhardt D., Zuber M., Kiowski W., Buser P.T., Dubach P., Resink T.J., Pfisterer M. Effects of percutaneous coronary interventions in silent ischaemia after myocardial infarction: the SWISSI II randomized controlled trial. JAMA. 2007;297:1985-1991. DOI: 10.1001/jama.297.18.1985.
2. Ассоциация сердечно-сосудистых хирургов России. Секция «Кардиология и визуализация в кардиохирургии» 2013-2017. www.heart-master.com [Association of cardiovascular surgeons of Russia. Sections “Cardiology and visualization in cardiac surgery” 2013-2017 www.heart-master.com] (In Russ).
3. De Bruyne B., Pijls N.H.J., Bindu M.D., For the FAME 2 Trial Investigators. N. Engl. J. Med. 2012;367:991-1001. DOI: 10.1056/ NEJMoa1205361.
4. Di Segni E., Higano S.T., Rihal Cs. Holmes Jr. D.R., Lennon R., Ler-man A. Incremental doses of intracoronary adenosine for the assessment of coronary velocity reserve for clinical decision making. Catheter Cardiovasc. Interv. 2001;54:34-40. DOI: 10.1002/ ccd.1234.
5. Yamada H., Azuma A., Hirasaki S., Kobara M., Akagi A., Shima T., Miyazaki H., Sugihara H., Kohno Y., Asayama J., Nakagawa M. In-tracoronary adenosine 5’-triphosphate as an alternative to pa-paverine for measuring coronary flow reserve. Am. J. Cardiol. 1994;74:940-951. DOI: 10.1016/0002-9149(94)90591-6.
6. Sonoda S., Takeuchi M., Nakashima Y., Kuroiwa A. Safety and optimal dose of intracoronary adenosine 5’-triphosphate for the measurement of coronary flow reserve. Am. Heart J. 1998;135:621-627. DOI: 10.1016/S0002-8703(98)70277-7.
7. Jeremias A., Filardo S.D., Whitbourn R.J., Kernoff R.S., Yeung A.C., Fitzgerald P.J., Yock P.G. Effects of intravenous and intracoronary 5’-triphosphate as compared with adenosine on coronary flow and pressure dynamics. Circulation. 2000;101:318-323. DOI: 10.1161/01.CIR.101.3.318.
8. Wilson R.F., White C.W. Intracoronary papaverine: An ideal coronary vasodilator for studies of the coronary circulation in conscious humans. Circulation. 1986;73:444-451. DOI: 10.1161/01. CIR.73.3.444.
9. Inoue T., Asahi S., Takayanagi K., Morooka S.,•Takabatake Y. QT prolongation and possibility of ventricular arrhythmias after intracoronary papaverine. Cardiology. 1994;84:9–13. DOI: 10.1159/000176323.
10. Vrolix M., Piessens J., De Geest H. Torsades de pointes after in-tracoronary papaverine. Eur. Heart J. 1991;12:273–276. DOI: 10.1093/oxfordjournals.eurheartj.a059880.
11. Kern M.J., Deligonul U., Serota H., Gudipati C., Buckingham T. Ventricular arrhythmia due to intracoronary papaverine: Analysis of QT intervals and coronary vasodilatory reserve. Catheter Cardiovasc. Diagn. 1990;19:229–236. DOI: 10.1002/ ccd.1810190402.
12. Wilson R.F., White C.W. Serious ventricular dysryhthmias after intracoronary papaverine. Am. J. Cardiol. 1988;62:1301–1302. DOI:10.1016/0002-9149(88)90281-0.
13. Даренский Д.И., Жарова Е.А., Матчин Ю.Г. Инвазивные методы определения функциональной значимости коронарных стенозов пограничной степени выраженности. Кардиологический вестник. 2016;2:80-89. [Darenskiy D.I., Zharova E.A., Matchin Yu.G. Assessmentof functional significance of intermediate coronary stenoses by invasive methods. Kardiologicheskij Vestnik. 2016;2:80-89] (In Russ).
14. Миронов В.М., Меркулов Е.В., Самко А.Н. Оценка фракционного резерва коронарного кровотока. Кардиология. 2012;8:66-71 [Mironov V.M., Merkulov E.V., Samko A.N. Assessment of Fractional Coronary Blood Flow Reserve. Kardiologiia. 2012;8:66-71] (In Russ).
15. Миронов В.М., Меркулов Е.В., Самко А.Н., Карпов Ю.А. Измерение фракционного резерва кровотока для выбора тактики лечения пациентов с многососудистым и многоуровневым поражением коронарного русла. Российский электронный журнал лучевой диагностики. 2014;4(4):32-38 [Mironov V.M., Merkulov E.V., Samko A.N., Karpov Yu.A. FFR measurement for decision making in multivessel and diffuse coronary artery disease. Russian Electronic Journal of Radiology. 2014;4(4):32-38] (In Russ).
16. De Bruyne B., Pijls N.H., Barbato E., Bartunek J., Bech J-W., Wijns W., Heyndrickx G. R. Intracoronary and intravenous adenosine 5’- triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans. Circulation. 2003;107:1877-1883. DOI: 10.1161/01. CIR.0000061950.24940.88.
17. Van der Voort P.H., van Hagen E., Hendrix G., van Gelder B., Bech J.W., Pijls N. Comparison of intravenous adeno-sine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve. Catheter Car-diovasc. Diagn. 1996;39:120–125. DOI: 10.1002/(SICI)1097-0304(199610)39:23.0.CO;2-H.
18. Коваль М. Обзор: Феномен «no-reflow» — ложка дегтя в бочке меда реваскуляризации. Medicine Review. 2008;5(05):32-36 [Koval’ M. Review: «No-reflow» fenomen — one spoonful of tar spoils a barrel of honey of revascularization. Medicine Review. 2008;5(05):32-36] (In Russ).
19. Идиосинкразия и феномен выделения гистамина. Медицина и здоровье. Новости медицины и здравоохранения. 2015 [Idiosyncrasy and the phenomenon of histamine release. Me-dicina i zdorov’e. Novosti mediciny i zdravoohranenija. 2015] (In Russ).`
20. Литовский И.А., Гордиенко А.В. Стандарты лечения кардиогенного шока: спорные и нерешенные вопросы. Вестник Российской военно-медицинской академии. 2016;3(55):204-211 [Litovskij I.A., Gordienko A.V. Standards of treatment of cardiogenic shock: contentious and unresolved issues. Vestnik of Russian military medical Academy. 2016;3(55):204-211] (In Russ).
Review
For citations:
Semukhina E.N., Semukhin M.V., Gapon L.I., Zyryanov I.P. A CASE OF DEVELOPMENT OF CARDIOGENIC SHOCK AFTER INTRA-ARTERIAL INJECTION OF PAPAVERINE DURING MEASURING OF FRACTIONAL FLOW RESERVE IN LEFT ANTERIOR DESCENDING ARTERY. Siberian Journal of Clinical and Experimental Medicine. 2017;32(4):59-64. (In Russ.) https://doi.org/10.29001/2073-8552-2017-32-4-59-64